Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
EQ
#3910
Equillium, Inc. Common Stock
1.9
2
USD
+12.94%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+12.94%
Changement Mensuel
-24.11%
Evolution sur 6 mois
+54.84%
Changement Annuel
+346.51%
Clôture Précédente
1.7
0
Open
1.9
2
Bid
Ask
Low
1.9
2
High
1.9
2
Volume
47
Marchés
Actions des Marchés US
Soins de Santé
EQ
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
29.04 M
34.28 M
34.41 M
35.25 M
35.61 M
63.23 M
—
Valuation ratios
Enterprise value
139.66 M
89.22 M
-18.16 M
2.67 M
8.56 M
67.72 M
128.45 M
Price to earnings ratio
—
—
-0.57
-1.93
-3.25
-3.97
-7.85
Price to sales ratio
—
—
2.27
0.71
0.64
220.4
231.93
Price to cash flow ratio
—
—
-4.09
-1.17
-1.39
-3.9
-7.83
Price to book ratio
—
—
1.12
1.13
1.39
3.11
4.47
Enterprise value to EBITDA ratio
-4.56
-2.13
0.37
-0.18
-0.96
-2.93
-5.52
Profitability ratios
Return on assets %
-0.35
-0.46
-0.8
-0.26
-0.32
-0.7
-1.22
Return on equity %
-0.43
-0.59
-1.95
-0.59
-0.42
-0.78
-2.22
Return on invested capital %
-11.66 K
-5 248.97
-1 884.87
-304.73
-381.07
-9 291.01
-12.11 K
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-9 849.33
-18.89 K
-393.91
-40.24
-20.12
-5 864.52
-23.1 K
EBITDA margin %
-9 613
-18.48 K
-391.07
-41.93
-21.62
-5 739.21
-22.64 K
Net margin %
-9 937.67
-19.53 K
-396.14
-36.96
-19.63
-5 557.82
-22.31 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
11.76
9.35
2.4
1.79
3.93
10.58
25.79
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0.19
0.56
1.08
0.01
0.03
Solvency ratios
Debt to assets ratio
0.1
0.12
0.06
—
—
—
—
Debt to equity ratio
0.12
0.16
0.14
—
—
—
—
Long term debt to total assets ratio
0.1
0.1
0.04
—
—
—
—
Long term debt to total equity ratio
0.12
0.13
0.1
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.26
-0.63
-0.54
-0.4
-0.5
EBIT per share
—
—
-1.84
-0.42
-0.23
-0.41
-0.55
EBITDA per share
—
—
-1.83
-0.44
-0.25
-0.4
-0.55
Total debt per share
—
—
0.13
—
—
—
—
Cash per share
—
—
2.11
1.18
0.64
0.53
1.76
Net current asset value per share
—
—
2.28
1.42
0.71
0.54
1.85
Tangible book value per share
—
—
0.95
0.65
0.54
0.5
1.41
Working capital per share
—
—
1.33
0.63
0.53
0.49
1.38
Book value per share
—
—
0.95
0.65
0.54
0.5
1.41
Nouvelles
Raymond James initie la couverture d’Equillium avec un achat fort
Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)
La vice-présidente d’Equillium (EQ) Zedelmayer vend pour 300.000$ d’actions
Equillium (EQ) SVP Zedelmayer sells $300k in shares
Equillium obtient un financement de 35 millions de dollars de RA Capital Management
Equillium secures $35M financing from RA Capital Management
Roth/MKM initie la couverture d’Equillium avec un achat sur son traitement de la colite ulcéreuse
Roth/MKM initiates Equillium stock with buy on ulcerative colitis drug
La vice-présidente d’Equillium Zedelmayer vend pour 328.000$ d’actions
Equillium SVP Zedelmayer sells $328k in shares
Stifel initie la couverture d’Equillium avec une recommandation d’achat sur le potentiel des MICI
Stifel initiates Equillium stock with buy rating on IBD potential